tiprankstipranks
Advertisement
Advertisement

TSE:KNE Stock Latest News

Company AnnouncementsKane Biotech’s revyve Wound Gel Gains Peer-Reviewed Validation for Tackling Antibiotic-Tolerant Biofilms
28d ago
PremiumCompany Announcements
Kane Biotech broadens U.S. reach with federal distributor deal and new sales force
1M ago
PremiumCompany Announcements
Kane Biotech’s revyve Wound Gel Gains Peer-Reviewed Validation in International Wound Journal
2M ago
PremiumCompany Announcements
Kane Biotech’s revyve Wound Gel Gains Peer-Reviewed Validation in International Wound Journal
2M ago
PremiumCompany Announcements
Kane Biotech Expands U.S. Distribution for revyve Wound Care Line
2M ago
PremiumCompany AnnouncementsKane Biotech Wins FDA Clearance and Expands Quality Certification for revyve Wound Care Line
2M ago
Premium
Company Announcements
Kane Biotech Restarts North American Sales Push and Bolsters Wound Care Leadership
2M ago
Kane Biotech Raises $700,000 in Insider-Led Private Placement
Premium
Company Announcements
Kane Biotech Raises $700,000 in Insider-Led Private Placement
4M ago
Kane Biotech Showcases Advancements in Wound Care at Industry Meeting
PremiumCompany Announcements
Kane Biotech Showcases Advancements in Wound Care at Industry Meeting
4M ago
Kane Biotech’s revyve Wound Gel Spray Gains Health Canada Approval
PremiumCompany Announcements
Kane Biotech’s revyve Wound Gel Spray Gains Health Canada Approval
4M ago
Kane Biotech Reports Q3 2025 Results Amid Strategic Progress in Wound Care Market
PremiumCompany Announcements
Kane Biotech Reports Q3 2025 Results Amid Strategic Progress in Wound Care Market
5M ago
Kane Biotech Launches $800,000 Private Placement Offering
PremiumCompany Announcements
Kane Biotech Launches $800,000 Private Placement Offering
5M ago
Kane Biotech’s revyve Gel Shows Promising Results in Wound Care
PremiumCompany AnnouncementsKane Biotech’s revyve Gel Shows Promising Results in Wound Care
5M ago
Kane Biotech’s New Acne Treatment Study: What Investors Need to Know
Premium
Company Announcements
Kane Biotech’s New Acne Treatment Study: What Investors Need to Know
6M ago
KNE
Kane Biotech Submits FDA Clearance for New Wound Cleanser
Premium
Company Announcements
Kane Biotech Submits FDA Clearance for New Wound Cleanser
7M ago
Kane Biotech Exceeds Enrollment Target in U.S. Studies for revyve® Wound Care Products
PremiumCompany Announcements
Kane Biotech Exceeds Enrollment Target in U.S. Studies for revyve® Wound Care Products
7M ago
Kane Biotech to Showcase revyve® Clinical Data at SAWC Fall Conference
PremiumCompany Announcements
Kane Biotech to Showcase revyve® Clinical Data at SAWC Fall Conference
7M ago
Kane Biotech Reports Q2 2025 Financials Amid Strategic Restructuring
PremiumCompany Announcements
Kane Biotech Reports Q2 2025 Financials Amid Strategic Restructuring
8M ago
Kane Biotech Highlights Promising revyve® Findings at Wound Care Conferences
PremiumCompany Announcements
Kane Biotech Highlights Promising revyve® Findings at Wound Care Conferences
9M ago
Kane Biotech to Showcase Innovations at Advanced Wound Care Summit
PremiumCompany AnnouncementsKane Biotech to Showcase Innovations at Advanced Wound Care Summit
9M ago
Kane Biotech Converts Loan to Debenture and Announces AGM Results
Premium
Company Announcements
Kane Biotech Converts Loan to Debenture and Announces AGM Results
10M ago
Kane Biotech Reorganizes Distribution and Financial Strategies Amid Clinical Advancements
Premium
Company Announcements
Kane Biotech Reorganizes Distribution and Financial Strategies Amid Clinical Advancements
10M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >